Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457
Stage IV Anal Cancer AJCC v8
M.D. Anderson Cancer CentervaccinePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
46 Active assets in the Stage IV Anal Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Federation Francophone de Cancerologie Digestive | Phase 3 | BB |
Carboplatin Dustin Deming | Phase 3 | BB |
Irinotecan University of Cincinnati | Phase 3 | BB |
Nivolumab Instituto do Cancer do Estado de São Paulo | Phase 3 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Federation Francophone de Cancerologie Digestive | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →